ICU Medical, Inc. develops, manufactures and sells innovative medical products used in infusion therapy and critical care applications. ICU Medical's product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. ICU Medical is headquartered in San Clemente, California.

Company profile
Ticker
ICUI
Exchange
Website
CEO
Vivek Jain
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Haemonetics • Hill-Rom • Nuvasive ...
SEC CIK
Corporate docs
Subsidiaries
ICU Medical Sales, Inc. • ICU Medical de Mexico • ICU Medical Europe S.r.l. • ICU World, Inc. • ICU Medical Bidco Ltd • ICU Medical Germany GmbH • ICU Medical B.V. • ICU Medical Australia Holdings Pty Limited • ICU Medical SA Pty Ltd • EXC Holding Corp. ...
IRS number
330022692
ICUI stock data
News

Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday
10 Aug 22
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
10 Aug 22
Smiths Acquisition Weighs On ICU Medical's Profitability, Shares Fall
9 Aug 22
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
9 Aug 22
Expert Ratings for ICU Medical
9 Aug 22
Press releases
Analyst ratings and price targets
Current price
Average target
$207.50
Low target
$190.00
High target
$225.00
Raymond James
Maintains
$190.00
Keybanc
Maintains
$225.00
Calendar
8 Aug 22
18 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 255.7M | 255.7M | 255.7M | 255.7M | 255.7M | 255.7M |
Cash burn (monthly) | 24.58M | 17.19M | 5.62M | 787.5K | 20.46M | (no burn) |
Cash used (since last report) | 40.48M | 28.32M | 9.25M | 1.3M | 33.7M | n/a |
Cash remaining | 215.22M | 227.38M | 246.44M | 254.4M | 221.99M | n/a |
Runway (months of cash) | 8.8 | 13.2 | 43.9 | 323.0 | 10.8 | n/a |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 May 22 | Jain Vivek | Common Stock | Gift | Dispose G | No | No | 0 | 30 | 0 | 15,469 |
17 May 22 | Greenberg David C. | NQSO Common Stock | Grant | Acquire A | No | No | 185.79 | 1,270 | 235.95K | 1,270 |
17 May 22 | Greenberg David C. | Common Stock Common Stock | Grant | Acquire A | No | No | 0 | 485 | 0 | 485 |
17 May 22 | Laurie Hernandez | NQSO Common Stock | Grant | Acquire A | No | No | 185.79 | 1,270 | 235.95K | 1,270 |
17 May 22 | Laurie Hernandez | Common Stock Common Stock | Grant | Acquire A | No | No | 0 | 485 | 0 | 485 |
17 May 22 | Abbey Donald | NQSO Common Stock | Grant | Acquire A | No | No | 185.79 | 1,270 | 235.95K | 1,270 |
17 May 22 | Abbey Donald | Common Stock Common Stock | Grant | Acquire A | No | No | 0 | 485 | 0 | 485 |
17 May 22 | Hoffmeister David F | Non-Quakified Stock Option Common Stock | Grant | Acquire A | No | No | 185.79 | 1,270 | 235.95K | 1,270 |
17 May 22 | Hoffmeister David F | Common Stock Common Stock | Grant | Acquire A | No | No | 0 | 485 | 0 | 485 |
Institutional ownership, Q2 2022
13F holders | Current |
---|---|
Total holders | 248 |
Opened positions | 28 |
Closed positions | 67 |
Increased positions | 97 |
Reduced positions | 78 |
13F shares | Current |
---|---|
Total value | 11.41B |
Total shares | 48.82M |
Total puts | 7.8K |
Total calls | 28.6K |
Total put/call ratio | 0.3 |
Largest owners | Shares | Value |
---|---|---|
PFE Pfizer | 25M | $7.33B |
TROW T. Rowe Price | 2.71M | $445.35M |
JHG Janus Henderson | 2.55M | $418.92M |
Smiths Group International | 2.5M | $576.48M |
Vanguard | 2.08M | $341.44M |
Wellington Management | 1.83M | $301.33M |
BLK Blackrock | 1.74M | $285.97M |
Nuance Investments | 1.01M | $165.86M |
JPM JPMorgan Chase & Co. | 758.7K | $124.72M |
STT State Street | 557.95K | $91.72M |
Financial report summary
?Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
building, Chinese, CNH, CZK, fact, hierarchy, inflationary, interpretive, JPY, judgment, notably, promissory, Renminbi, resource, respond
Removed:
Austin, communicated, disclose, file, submit, summarized, timely
Financial reports
Current reports
8-K
ICU Medical Announces Second Quarter 2022 Results
8 Aug 22
8-K
Submission of Matters to a Vote of Security Holders
18 May 22
8-K
ICU Medical Announces First Quarter 2022 Results
9 May 22
8-K
Departure of Directors or Certain Officers
20 Apr 22
8-K/A
Report of Independent Auditors
21 Mar 22
8-K
ICU Medical Announces Fourth Quarter 2021 Results
24 Feb 22
8-K
Departure of Directors or Certain Officers
18 Feb 22
8-K
Departure of Directors or Certain Officers
1 Feb 22
8-K
ICU Medical Completes the Acquisition of Smiths Medical from Smiths Group plc
7 Jan 22
8-K
Departure of Directors or Certain Officers
4 Jan 22
Registration and prospectus
S-3ASR
Automatic shelf registration
15 Nov 18
8-A12B/A
Registration of securities on exchange (amended)
26 Feb 18
S-8
Registration of securities for employees
29 Jun 17
S-8
Registration of securities for employees
19 Aug 14
S-8
Registration of securities for employees
29 Jun 11
8-A12B
Registration of securities on exchange
17 Feb 10
S-8
Registration of securities for employees
19 May 04
S-8
Registration of securities for employees
19 May 04
S-8
Registration of securities for employees
13 Jun 02
S-8
Registration of securities for employees
13 Jun 02
Other
SD
Conflict minerals disclosure
31 May 22
SD
Conflict minerals disclosure
26 May 21
SD
Conflict minerals disclosure
1 Jun 20
SD
Conflict minerals disclosure
31 May 19
SD
Conflict minerals disclosure
31 May 18
UPLOAD
Letter from SEC
11 Sep 17
CORRESP
Correspondence with SEC
4 Sep 17
UPLOAD
Letter from SEC
29 Aug 17
CORRESP
Correspondence with SEC
9 Aug 17
UPLOAD
Letter from SEC
26 Jul 17
Ownership
SC 13G
ICU MEDICAL / T. Rowe Price Investment Management ownership change
10 Aug 22
SC 13G/A
ICU MEDICAL / PRICE T ROWE ASSOCIATES ownership change
10 Aug 22
4
ICU MEDICAL / Vivek Jain ownership change
23 May 22
4
ICU MEDICAL / KOLLEEN T KENNEDY ownership change
18 May 22
4
ICU MEDICAL / David F Hoffmeister ownership change
18 May 22
4
ICU MEDICAL / Donald Abbey ownership change
18 May 22
4
ICU MEDICAL / ELISHA W FINNEY ownership change
18 May 22
4
ICU MEDICAL / Laurie Hernandez ownership change
18 May 22
4
ICU MEDICAL / David C. Greenberg ownership change
18 May 22
4
ICU MEDICAL / GEORGE A LOPEZ ownership change
13 May 22
Patents
Utility
Peritoneal dialysis transfer set with antimicrobial properties
2 Aug 22
The disclosure provides a method for preventing infection and microbial ingress in medical device connections between peritoneal dialysis transfer sets and peritoneal dialysis catheters.
Utility
User interface improvements for medical devices
26 Jul 22
A method and system is disclosed for operating a medical device with or without a cassette in place.
Utility
Device for Delivery of Antimicrobial Agent into a Medical Device
21 Jul 22
A system, method, and article for delivering an antimicrobial agent into the lumen of a trans-dermal catheter are disclosed.
Utility
Device for delivery of antimicrobial agent into trans-dermal catheter
19 Jul 22
A system, method, and article for delivering an antimicrobial agent into the lumen of a trans-dermal catheter are disclosed.
Design
Port retention clip
12 Jul 22
Inventors: Amanda Punim
Transcripts
2022 Q2
Earnings call transcript
9 Aug 22
2022 Q1
Earnings call transcript
9 May 22
2021 Q4
Earnings call transcript
26 Feb 22
2021 Q3
Earnings call transcript
4 Nov 21
2021 Q2
Earnings call transcript
8 Aug 21
2021 Q1
Earnings call transcript
8 May 21
2020 Q4
Earnings call transcript
26 Feb 21
2020 Q3
Earnings call transcript
7 Nov 20
2020 Q2
Earnings call transcript
10 Aug 20
2020 Q1
Earnings call transcript
10 May 20
Reddit threads
Daily Discussion Thread - August 5th, 2022
5 Aug 22
Daily Discussion Thread - May 9th, 2022
9 May 22
Daily Discussion Thread - May 6th, 2022
6 May 22
What stocks are on your close watchlist that you're buying this week or in the near future?
4 Apr 22
Daily Discussion Thread - February 24th, 2022
24 Feb 22
Daily Discussion Thread - February 23rd, 2022
23 Feb 22
Daily Discussion Thread - February 22nd, 2022
22 Feb 22
Daily Discussion Thread - February 21st, 2022
21 Feb 22
Daily Discussion Thread - November 3rd, 2021
3 Nov 21
Daily Discussion Thread - November 2nd, 2021
2 Nov 21